Detalhe da pesquisa
1.
Two-Pore Domain Potassium Channels as Drug Targets: Anesthesia and Beyond.
Annu Rev Pharmacol Toxicol
; 61: 401-420, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32679007
2.
Pharmacological Approaches to Studying Potassium Channels.
Handb Exp Pharmacol
; 267: 83-111, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34195873
3.
Opportunistic screening for atrial fibrillation by clinical pharmacists in UK general practice during the influenza vaccination season: A cross-sectional feasibility study.
PLoS Med
; 17(7): e1003197, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32678820
4.
Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension.
J Physiol
; 597(4): 1087-1101, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30365877
5.
Pranlukast is a novel small molecule activator of the two-pore domain potassium channel TREK2.
Biochem Biophys Res Commun
; 520(1): 35-40, 2019 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31564414
6.
HIV transgene expression impairs K+ channel function in the pulmonary vasculature.
Am J Physiol Lung Cell Mol Physiol
; 315(5): L711-L723, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30136611
7.
Terbinafine is a novel and selective activator of the two-pore domain potassium channel TASK3.
Biochem Biophys Res Commun
; 493(1): 444-450, 2017 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28882594
8.
TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications.
Eur Respir J
; 50(5)2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29122916
9.
Enhancement of TWIK-related acid-sensitive potassium channel 3 (TASK3) two-pore domain potassium channel activity by tumor necrosis factor α.
J Biol Chem
; 289(3): 1388-401, 2014 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24307172
10.
Two-pore domain potassium channels: potential therapeutic targets for the treatment of pain.
Pflugers Arch
; 467(5): 931-43, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25420526
11.
Recovery of current through mutated TASK3 potassium channels underlying Birk Barel syndrome.
Mol Pharmacol
; 85(3): 397-407, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24342771
12.
Influence of the N terminus on the biophysical properties and pharmacology of TREK1 potassium channels.
Mol Pharmacol
; 85(5): 671-81, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24509840
13.
TASK-3, two-pore potassium channels, contribute to circadian rhythms in the electrical properties of the suprachiasmatic nucleus and play a role in driving stable behavioural photic entrainment.
Chronobiol Int
; : 1-15, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38757583
14.
The Concise Guide to PHARMACOLOGY 2023/24: Nuclear hormone receptors.
Br J Pharmacol
; 180 Suppl 2: S223-S240, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123152
15.
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes.
Br J Pharmacol
; 180 Suppl 2: S289-S373, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123154
16.
The Concise Guide to PHARMACOLOGY 2023/24: Transporters.
Br J Pharmacol
; 180 Suppl 2: S374-S469, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123156
17.
The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors.
Br J Pharmacol
; 180 Suppl 2: S241-S288, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123155
18.
The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets.
Br J Pharmacol
; 180 Suppl 2: S1-S22, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123153
19.
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.
Br J Pharmacol
; 180 Suppl 2: S23-S144, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123151
20.
The Concise Guide to PHARMACOLOGY 2023/24: Ion channels.
Br J Pharmacol
; 180 Suppl 2: S145-S222, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123150